ARIDIS PHARMACEUTICALS INC (ARDS)
Institutional ownership reported to the SEC as of Q2 2026, across 24 quarters.
1
Reporting holders
$0
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Strengthening Families & Communities, LLC | $0 | 3,000 | 0.00% | 2q | HELD |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-14 | 13G/A | Armistice Capital, LLCwith 1 co-filers | 11.4% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $0 | 3,000 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $1 | 3,000 | 1 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $3 | 3,000 | 1 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $10 | 150 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $1.4K | 14,077 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 14 | $227.5K | 1,015,518 | 2 | 3 | 1 | 1.8% |
| Q1 2023 | 18 | $1.1M | 3,426,804 | 6 | 0 | 4 | 0.9% |
| Q4 2022 | 13 | $3.7M | 3,154,520 | 4 | 2 | 2 | 0.2% |
| Q3 2022 | 16 | $1.8M | 1,926,605 | 1 | 5 | 4 | 0.6% |
| Q2 2022 | 19 | $2.1M | 1,868,871 | 3 | 4 | 5 | 0.5% |
| Q1 2022 | 21 | $3.4M | 1,922,201 | 6 | 5 | 2 | 0.0% |
| Q4 2021 | 20 | $3.4M | 1,324,275 | 10 | 5 | 0 | 9.7% |
| Q3 2021 | 17 | $7.3M | 1,991,394 | 7 | 4 | 1 | 0.0% |
| Q2 2021 | 13 | $7.9M | 1,077,025 | 3 | 5 | 2 | 0.0% |
| Q1 2021 | 10 | $6.0M | 1,011,836 | 3 | 5 | 1 | 0.0% |
| Q4 2020 | 11 | $4.5M | 741,213 | 4 | 2 | 1 | 0.0% |
| Q3 2020 | 7 | $1.3M | 182,604 | 1 | 3 | 1 | 0.0% |
| Q2 2020 | 6 | $710.7K | 107,034 | 2 | 2 | 0 | 0.0% |
| Q1 2020 | 6 | $556.0K | 96,364 | 2 | 1 | 1 | 0.0% |
| Q4 2019 | 5 | $411.0K | 92,497 | 0 | 1 | 3 | 0.0% |
| Q3 2019 | 7 | $747.0K | 111,245 | 3 | 1 | 1 | 0.0% |
| Q2 2019 | 5 | $477.0K | 46,980 | 2 | 1 | 1 | 0.0% |
| Q1 2019 | 4 | $642.0K | 58,379 | 1 | 0 | 2 | 0.0% |
| Q4 2018 | 4 | $161.0K | 14,596 | 0 | 0 | 0 | 0.0% |